Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy (Q33389719)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy |
scientific article |
Statements
1 reference
Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy (English)
1 reference
Kensei Tobinai
1 reference
Shunji Takahashi
1 reference
Kiyohiko Hatake
1 reference
Michinori Ogura
1 reference
Toshiki Uchida
1 reference
Masanobu Kasai
1 reference
Takashi Oyama
1 reference
Tatsuya Suzuki
1 reference
Takashi Watanabe
1 reference
Teruhisa Azuma
1 reference
Masakazu Mori
1 reference
Yasuhito Terui
1 reference
Masahiro Yokoyama
1 reference
Yuko Mishima
1 reference
Chiho Ono
1 reference
Junko Ohata
1 reference
23 April 2010
1 reference
1 reference
101
1 reference
1840-1845
1 reference
Identifiers
1 reference
1 reference